ReviewCancers2019

PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics.

Alia Ghoneum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.